58186-26-8Relevant articles and documents
Determination of idebenone in plasma by HPLC with post-column fluorescence derivatization using 2-cyanoacetamide
Nohara, Yukio,Suzuki, Junko,Yamazaki, Yoji,Kubo, Hiroaki
, p. 598 - 602 (2012)
Idebenone is a benzoquinone analog that is used in the treatment of several neurological disorders including Friedreich's ataxia. It was found that the reaction of idebenone with 2-cyanoacetamide under alkaline conditions generates fluorescent products, a
A strategy for suppressing redox stress within mitochondria
Arce, Pablo M.,Khdour, Omar M.,Goldschmidt, Ruth,Armstrong, Jeffrey S.,Hecht, Sidney M.
supporting information; scheme or table, p. 608 - 613 (2011/10/04)
An aza analogue (1) of the experimental neuroprotective drug idebenone has been prepared and evaluated. The compound quenches lipid peroxidation more effectively than α-tocopherol and potently suppresses reactive oxygen species in cells under oxidative stress. It is thought to do so via a catalytic cycle in which both forms of oxidative stress are suppressed simultaneously. Consequently, the compound effectively protects cultured CEM leukemia cells and Friedreich's ataxia fibroblasts from oxidative stress more effectively than idebenone or idebenol.
Aralkyl carboxylic acid compounds
-
, (2008/06/13)
Novel compounds of the formulae STR1 wherein R represents lower alkyl or lower alkoxy, A represents --CH2 --, --CO-- or STR2 n represents an integer of 1 to 8, X represents hydrogen or hydroxyl which may be protected and Y represents hydroxyl which may be protected, and their esters show an excellent action on the lysosomal membranes of cells, and exhibit excellent pharmacological activities such as physiologic host defense control activity, especially immuno-potentiating activity.